메뉴 건너뛰기




Volumn 15, Issue 1, 2000, Pages 15-29

Pretargeted radioimmunotherapy (PRIT(TM)) for treatment of non-Hodgkin's lymphoma (NHL): Initial phase I/II study results

Author keywords

90Y; Non Hodgkin's lymphoma; Pretargeted radioimmunotherapy; PRIT; Radioimmunotherapy; RIT; Streptavidin

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; BIOTIN; CD20 ANTIGEN; MONOCLONAL ANTIBODY; RITUXIMAB; STREPTAVIDIN; YTTRIUM 90;

EID: 18544410002     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2000.15.15     Document Type: Article
Times cited : (130)

References (25)
  • 1
    • 0033972577 scopus 로고    scopus 로고
    • Pretargeted Radioimmunotherapy (PRIT) using antibody-streptavidin conjugate and radiobiotin: Phase I study to optimize therapy protocol
    • In press
    • Breitz HB., Weiden PL, Beaumier P, Axworthy DB, Seiler C, Su F-M, Graves S, Bryan K, Reno J. Pretargeted Radioimmunotherapy (PRIT) using Antibody-Streptavidin Conjugate and Radiobiotin: Phase I Study to Optimize Therapy Protocol. J Nucl Med 41:In press,2000.
    • (2000) J Nucl Med , vol.41
    • Breitz, H.B.1    Weiden, P.L.2    Beaumier, P.3    Axworthy, D.B.4    Seiler, C.5    Su, F.-M.6    Graves, S.7    Bryan, K.8    Reno, J.9
  • 3
    • 0025060324 scopus 로고
    • The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas
    • Jaffe ES. The role of immunophenotypic markers in the classification of non-Hodgkin's lymphomas. Semin Oncol 1990;17:11-19.
    • (1990) Semin Oncol , vol.17 , pp. 11-19
    • Jaffe, E.S.1
  • 5
    • 0025288944 scopus 로고
    • Avidin and Streptavidin
    • Wilchek M and Bayer E, eds. Methods of Enzymology
    • Green NM. Avidin and Streptavidin. In: Wilchek M and Bayer E, eds. Methods of Enzymology. Avidin-Biotin Technology. 1990;184:51-67.
    • (1990) Avidin-biotin Technology , vol.184 , pp. 51-67
    • Green, N.M.1
  • 7
    • 0003456152 scopus 로고    scopus 로고
    • 90Y Dual isotope scintillation counting method for patient samples from pretargeted cancer therapy phase I trial
    • 90Y Dual isotope scintillation counting method for patient samples from pretargeted cancer therapy phase I trial. J Nucl Med 1996;37:145P.
    • (1996) J Nucl Med , vol.37
    • Su, F.-M.1    Hickey, J.J.2    Taylor, C.3    Beaumier, P.4
  • 12
    • 0031872907 scopus 로고    scopus 로고
    • Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates
    • Press OW. Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies and immunoconjugates. Cancer J Sci Am 4 Suppl 1998;2:S19-26.
    • (1998) Cancer J Sci Am 4 Suppl , vol.2
    • Press, O.W.1
  • 17
    • 0000968039 scopus 로고    scopus 로고
    • Multicenter phase III study of iodine-131 tositumomab (anti-B1 antibody) for chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL)
    • Kaminski M, Zelenetz A, Press O, Selah M, Leonard J, Fehrenbacher L, Stagg R, Kross S, Tidmarsh G, Knox S, Vose J. Multicenter phase III study of iodine-131 tositumomab (anti-B1 antibody) for chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL). Blood 1998;92 Suppl 1:316a. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-24.
    • (1998) Blood , vol.92 , Issue.SUPPL. 1
    • Kaminski, M.1    Zelenetz, A.2    Press, O.3    Selah, M.4    Leonard, J.5    Fehrenbacher, L.6    Stagg, R.7    Kross, S.8    Tidmarsh, G.9    Knox, S.10    Vose, J.11
  • 18
    • 0027484445 scopus 로고
    • Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support
    • Kaminski M, Zelenetz A, Press O, Selah M, Leonard J, Fehrenbacher L, Stagg R, Kross S, Tidmarsh G, Knox S, Vose J. Multicenter phase III study of iodine-131 tositumomab (anti-B1 antibody) for chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL). Blood 1998;92 Suppl 1:316a. Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B, et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;329:1219-24.
    • (1993) N Engl J Med , vol.329 , pp. 1219-1224
    • Press, O.W.1    Eary, J.F.2    Appelbaum, F.R.3    Martin, P.J.4    Badger, C.C.5    Nelp, W.B.6    Glenn, S.7    Butchko, G.8    Fisher, D.9    Porter, B.10
  • 22
    • 0031993168 scopus 로고    scopus 로고
    • Antibody pretargeted radiotherapy: A new approach and a second chance
    • Fritzberg AR. Antibody pretargeted radiotherapy: a new approach and a second chance. J Nucl Med 1998;39:20N-22N.
    • (1998) J Nucl Med , vol.39
    • Fritzberg, A.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.